Literature DB >> 29422974

Low risk HPV-6E6 induces apoptosis in bone marrow-derived dendritic cells.

Lina Sun1, Lei Zhao2, Dan Li1, Shuai Xu1, Xuexin Hou1, Zhenjun Li1.   

Abstract

The present study assessed the subcellular localization and apoptotic potential of low-risk human papilloma virus 6E6 (HPV-6E6), expressed in bone marrow-derived dendritic cells (DCs). DCs were obtained from C57BL/6 mice and transfected with a pGFP-6E6 plasmid. The subcellular localization of E6 was determined by tracing green fluorescent protein (GFP) using fluorescence microscopy. Apoptosis was assessed by staining nuclei with DAPI and performing an apoptosis-based flow cytometry assay. The co-localization of E6 and p53 was also investigated using confocal microscopy. In addition, the expression of apoptosis-associated proteins was analyzed using immunoblotting. The results of the present study demonstrated that low-risk HPV-6E6 is predominantly localized in the cytoplasm of DCs. Furthermore, p53 was upregulated in DCs transfected with pGFP-6E6 and co-localized with GFP-6E6 in the cytoplasm. DCs transfected with a control pGFP plasmid did not undergo apoptosis, whereas cells transfected with pGFP-6E6 did, as indicated by the presence of cell debris and condensation of the nuclei. Furthermore, the expression of apoptosis-associated proteins, including p53, BCL2 associated X apoptosis regulator (Bax), BCL2 homologous antagonist/killer (Bak) and cytochrome c, were significantly higher in DCs expressing low-risk E6 than in control cells. Therefore, the current study demonstrated that low-risk HPV-6E6 is predominantly located in the cytoplasm of DCs and induces apoptosis. This may be an important mechanism that explains why low-risk HPV is unable to induce malignant transformation.

Entities:  

Keywords:  apoptosis; green fluorescent protein; human papilloma virus-6E6; location

Year:  2017        PMID: 29422974      PMCID: PMC5772942          DOI: 10.3892/ol.2017.7417

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  18 in total

1.  Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine.

Authors:  Gao-Na Shi; Chuang-Nian Zhang; Rong Xu; Jin-Feng Niu; Hui-Juan Song; Xiu-Yuan Zhang; Wei-Wei Wang; Yan-Ming Wang; Chen Li; Xiao-Qing Wei; De-Ling Kong
Journal:  Biomaterials       Date:  2016-10-29       Impact factor: 12.479

2.  Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector.

Authors:  Y Liu; M Chiriva-Internati; F Grizzi; E Salati; J J Roman; S Lim; P L Hermonat
Journal:  Cancer Gene Ther       Date:  2001-12       Impact factor: 5.987

3.  High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation.

Authors:  X Li; P Coffino
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

4.  Effects of Epstein-Barr virus on the development of dendritic cells derived from cord blood monocytes: an essential role for apoptosis.

Authors:  Juan-Juan Wang; Yu-Feng Li; Ying-Ying Jin; Xi Wang; Tong-Xin Chen
Journal:  Braz J Infect Dis       Date:  2012 Jan-Feb       Impact factor: 1.949

5.  Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.

Authors:  Eva Kehmeier; Heiko Rühl; Britta Voland; Melissa Conrad Stöppler; Elliot Androphy; Hubert Stöppler
Journal:  Virology       Date:  2002-07-20       Impact factor: 3.616

6.  Two different HPV-11E6 fusion proteins trap p53 in the cytoplasm and induce apoptosis.

Authors:  Lina Sun; Ge Zhang; Ting Lei; Chen Huang; Tusheng Song; Lusheng Si
Journal:  Cancer Biol Ther       Date:  2008-12       Impact factor: 4.742

7.  Co-localization of the tumor-suppressor protein p53 and human papillomavirus E6 protein in human cervical carcinoma cell lines.

Authors:  X H Liang; M Volkmann; R Klein; B Herman; S J Lockett
Journal:  Oncogene       Date:  1993-10       Impact factor: 9.867

8.  Comparative study on E6 and E7 genes of some cutaneous and genital papillomaviruses of human origin for their ability to transform 3Y1 cells.

Authors:  A Hiraiwa; T Kiyono; K Segawa; K R Utsumi; M Ohashi; M Ishibashi
Journal:  Virology       Date:  1993-01       Impact factor: 3.616

9.  Signals that dictate nuclear localization of human papillomavirus type 16 oncoprotein E6 in living cells.

Authors:  Mingfang Tao; Michael Kruhlak; Shuhua Xia; Elliot Androphy; Zhi-Ming Zheng
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

10.  Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53.

Authors:  Denise Martinez-Zapien; Francesc Xavier Ruiz; Juline Poirson; André Mitschler; Juan Ramirez; Anne Forster; Alexandra Cousido-Siah; Murielle Masson; Scott Vande Pol; Alberto Podjarny; Gilles Travé; Katia Zanier
Journal:  Nature       Date:  2016-01-20       Impact factor: 49.962

View more
  1 in total

1.  Transcriptional Profiles of Murine Bone Marrow-Derived Dendritic Cells in Response to Peste des Petits Ruminants Virus.

Authors:  Lingxia Li; Jinyan Wu; Dan Liu; Guoyu Du; Yongsheng Liu; Youjun Shang; Xiangtao Liu
Journal:  Vet Sci       Date:  2019-11-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.